Business Description
Global Health Ltd
ISIN : INE474Q01031
Compare
Compare
Traded in other countries / regions
MEDANTA.India IPO Date
2022-11-16Description
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.51 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 0.92 | |||||
| Interest Coverage | 8.87 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 15.18 | |||||
| Beneish M-Score | -1.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 29.1 | |||||
| 3-Year EBITDA Growth Rate | 54.4 | |||||
| 3-Year EPS without NRI Growth Rate | 129.7 | |||||
| 3-Year FCF Growth Rate | 48.3 | |||||
| 3-Year Book Growth Rate | 26.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.6 | |||||
| 9-Day RSI | 17.75 | |||||
| 14-Day RSI | 24.7 | |||||
| 6-1 Month Momentum % | 59.72 | |||||
| 12-1 Month Momentum % | 150.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.44 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.96 | |||||
| Days Inventory | 32.13 | |||||
| Days Sales Outstanding | 24.75 | |||||
| Days Payable | 97.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.1 | |||||
| Shareholder Yield % | 0.92 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.81 | |||||
| Operating Margin % | 20.02 | |||||
| Net Margin % | 14.6 | |||||
| FCF Margin % | 10.18 | |||||
| ROE % | 17.95 | |||||
| ROA % | 11.47 | |||||
| ROIC % | 16.19 | |||||
| ROC (Joel Greenblatt) % | 28.06 | |||||
| ROCE % | 19.71 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 66.53 | |||||
| PE Ratio without NRI | 63.45 | |||||
| PS Ratio | 9.71 | |||||
| PB Ratio | 10.94 | |||||
| Price-to-Tangible-Book | 10.96 | |||||
| Price-to-Free-Cash-Flow | 95.31 | |||||
| Price-to-Operating-Cash-Flow | 51.93 | |||||
| EV-to-EBIT | 44.75 | |||||
| EV-to-EBITDA | 35.9 | |||||
| EV-to-Revenue | 9.58 | |||||
| EV-to-FCF | 94.06 | |||||
| Price-to-Graham-Number | 5.56 | |||||
| Price-to-Net-Current-Asset-Value | 288.19 | |||||
| Earnings Yield (Greenblatt) % | 2.23 | |||||
| FCF Yield % | 1.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Global Health Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 32,751.11 | ||
| EPS (TTM) (₹) | 17.79 | ||
| Beta | 0 | ||
| Volatility % | 29.34 | ||
| 14-Day RSI | 24.7 | ||
| 14-Day ATR (₹) | 54.568068 | ||
| 20-Day SMA (₹) | 1377.78 | ||
| 12-1 Month Momentum % | 150.2 | ||
| 52-Week Range (₹) | 577 - 1513.9 | ||
| Shares Outstanding (Mil) | 268.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Global Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Global Health Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Global Health Ltd Frequently Asked Questions
What is Global Health Ltd(NSE:MEDANTA)'s stock price today?
The current price of NSE:MEDANTA is ₹1184.45. The 52 week high of NSE:MEDANTA is ₹1513.90 and 52 week low is ₹577.00.
When is next earnings date of Global Health Ltd(NSE:MEDANTA)?
The next earnings date of Global Health Ltd(NSE:MEDANTA) is .
Does Global Health Ltd(NSE:MEDANTA) pay dividends? If so, how much?
Global Health Ltd(NSE:MEDANTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers